ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 107660 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 107660; 2) Community: the network communities that were significantly associated with the response to NSC 107660; 3) Molecule: the relationships between components within communities and NSC 107660; 4) MDR: the compounds that were significantly associated with the NSC 107660.

NSC Compound Enrichment Correlation
NSC 723732 8-{4-[6-(4-flurophenyl)-2-methyl-4-pyrimidinyloxy]butoxy}-7- methoxy-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a ][1,4]diazepin-5-one 0.00265144454581183 0.13669858
NSC 740 Methotrexate 0.00265144454581183 0.44279001
NSC 128687 6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-6-imino-3-(phosphonooxy)-, (2R-(2.alpha.,3.beta.,3a.beta.,9a.beta.))- (9CI) 0.00286159651545682 0.19183608
NSC 222722 Null 0.00286159651545682 0.29673015
NSC 258812 N,N-Dimethyldaunomycin hydrochloride 0.00286159651545682 0.4621436
NSC 618296 Null 0.00286159651545682 0.076113026
NSC 635958 Null 0.00286159651545682 0.35984558
NSC 671119 Null 0.00286159651545682 0.4985036
NSC 682841 Null 0.00286159651545682 0.37336039
NSC 686385 Null 0.00286159651545682 0.26000497
Total:108  Current:14    [First] [Prev] [Next] [Last]